Bruce Dezube

Bruce Dezube is a seasoned medical professional with extensive experience in oncology and clinical development. Currently serving as Senior Vice President of Clinical Development at Xilio Therapeutics, Inc., Bruce previously held significant roles at Mustang Bio, including Chief Medical Officer and Senior Vice President, where responsibilities included preparing Investigational New Drug submissions and leading clinical strategy. Notable prior positions include Alkermes Fellow/Vice President of Oncology and Medical Director at both TESARO, Inc. and Takeda Oncology. Bruce's academic credentials include an M.D. from Tufts University School of Medicine, an M.A. in Chemistry from Harvard, and a Bachelor's degree in Chemistry from Rutgers University, complemented by a tenure as an Associate Professor at Harvard Medical School.